Journal article icon

Journal article

The diversity and breadth of cancer cell fatty acid metabolism

Abstract:
The Tp53 gene is a well-known tumour suppressor, mutation of which (e.g. prevention of Ser312 phosphorylation) induces deletion or expression of an inactive p53 protein to increase the susceptibility of tumour occurance. However, the role of Tp53 gene in maintaining metabolic homeostasis for regulating physio-pathological activities is still not well-understood. This study aimed to use the lipidomics study as a systematic approach to understand the relationship between the phenotypic effects of Tp53 mutation on lipid-related endogenous metabolites. Plasma and liver samples from mice carrying a Tp53 Ser312 to Ala mutation and wild type mice were collected, lipids were extracted by liquid–liquid extraction method and analyzed by the RPLC-LTQ-FTMS for the lipidomics study. Our results indicated that defect in Ser312 phosphorylation of Tp53 leads the lipid disturbance (e.g. triacylglycerols) for fatty accumulation and fatty liver susceptibility, which is with preference of females. Histological observation by staining with haematoxylin and eosin further validated our lipidomics findings. To our conclusion, fatty liver occurrence may have different phenotypes, one of which is strongly linked with the Tp53 mutation and is susceptible in females. Lipidomics as a technique to detect a great number of endogenous compounds provides precise metabolic information that may further help improve personalized diagnosis of Chronic hepatic diseases
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s40170-020-00237-2

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Radcliffe Department of Medicine
Sub department:
RDM-Strategic
Role:
Author
ORCID:
0000-0002-6666-6871
More by this author
Role:
Author
ORCID:
0000-0003-2698-3220
More by this author
Role:
Author
ORCID:
0000-0003-3922-1137


More from this funder
Funder identifier:
10.13039/100008719
Grant:
MRTA3


Publisher:
BioMed Central
Journal:
Cancer and Metabolism More from this journal
Volume:
9
Issue:
1
Pages:
2-2
Article number:
2
Publication date:
2021-01-07
DOI:
EISSN:
2049-3002
ISSN:
2049-3002


Language:
English
Keywords:
Pubs id:
1160060
Local pid:
pubs:1160060
Source identifiers:
W3120949185
Deposit date:
2026-02-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP